The Scripps Research Institute

Joel Buxbaum, MD is a Professor of molecular medicine emeritus at The Scripps Research Institute and Consulting Chief Medical Officer at Protego Biopharma, La…

Jeffery Kelly, PhD

Subscribe to

Expert and Community Perspectives on Attruby®

In this special session, Dr. Barry Trachtenberg and members of the ATTR amyloidosis community came together to share medical insights and lived experiences related to Attruby™ (acoramidis). This expert-led discussion explores the clinical data, the patient perspective, and what lies ahead for those considering or currently taking Attruby.